Details

Last Funding Type

Grant

Last Funding Money Raised

$17.30M

Industries

Biopharma,Biotechnology,Pharmaceutical

Founded date

Jan 1, 2001

Number Of Employee

101 - 250

Operating Status

Active

Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company applying its proprietary Anticalin® technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia and other medical conditions with a high unmet medical need.
Anticalins are recombinantly engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. Our libraries of more than 100 billion different Anticalins can virtually bind to any target of interest.